Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Mayo Clinic and Foundation, 200 First Street SW, Rochester, MN 55905, USA. borlaug.barry@mayo.edu
Nearly half of all patients who have heart failure have preserved ejection fraction (HFpEF). Patients who have HFpEF tend to be older, female, and hypertensive, and characteristically display increased ventricular and arterial stiffening. In this article, we discuss the pathophysiology of abnormal ventriculoarterial stiffening and how it affects ventricular function, cardiovascular hemodynamics, reserve capacity, and symptoms. We conclude by exploring how novel treatment strategies targeting abnormal ventricular-arterial interaction might prove useful in the treatment of patients who have HFpEF.
Copyright © 2011 Elsevier Inc. All rights reserved.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on